-
-
Pfizer (PFE.US) and AbbVie (ABBV.US) Meet Rival! Eli Lilly (LLY.US) BTK Inhibitor Achieves Primary Endpoint in Phase III Clinical Trial
According to our financial news app, Pfizer (PFE.US) announced on Tuesday that its Bruton\'s tyrosine kinase (BTK) inhibitor, Jaypirca, has achieved the primary research endpoint in a phase III head-t
